JPH10287678A - ピラノアジン誘導体 - Google Patents

ピラノアジン誘導体

Info

Publication number
JPH10287678A
JPH10287678A JP9344697A JP9344697A JPH10287678A JP H10287678 A JPH10287678 A JP H10287678A JP 9344697 A JP9344697 A JP 9344697A JP 9344697 A JP9344697 A JP 9344697A JP H10287678 A JPH10287678 A JP H10287678A
Authority
JP
Japan
Prior art keywords
compound
mmol
added
solvent
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9344697A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10287678A5 (enExample
Inventor
Tsutomu Akama
勉 赤間
Mayumi Miyata
真由美 宮田
Hiroyuki Ishida
浩幸 石田
Shiro Akinaga
士朗 秋永
Katsunari Gomi
克成 五味
Hiromitsu Saito
博満 斉藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP9344697A priority Critical patent/JPH10287678A/ja
Publication of JPH10287678A publication Critical patent/JPH10287678A/ja
Publication of JPH10287678A5 publication Critical patent/JPH10287678A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP9344697A 1997-04-11 1997-04-11 ピラノアジン誘導体 Pending JPH10287678A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9344697A JPH10287678A (ja) 1997-04-11 1997-04-11 ピラノアジン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9344697A JPH10287678A (ja) 1997-04-11 1997-04-11 ピラノアジン誘導体

Publications (2)

Publication Number Publication Date
JPH10287678A true JPH10287678A (ja) 1998-10-27
JPH10287678A5 JPH10287678A5 (enExample) 2005-03-03

Family

ID=14082562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9344697A Pending JPH10287678A (ja) 1997-04-11 1997-04-11 ピラノアジン誘導体

Country Status (1)

Country Link
JP (1) JPH10287678A (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013083024A1 (zh) * 2011-12-08 2013-06-13 上海如絮生物科技有限公司 一种苯并噻唑类化合物、其中间体、制备方法和应用
US8889698B2 (en) 2007-02-01 2014-11-18 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9238640B2 (en) 2009-03-18 2016-01-19 Resverlogix Corp. Anti-inflammatory agents
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
US9610251B2 (en) 2011-11-01 2017-04-04 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889698B2 (en) 2007-02-01 2014-11-18 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US9199990B2 (en) 2007-02-01 2015-12-01 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US10532054B2 (en) 2007-02-01 2020-01-14 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
US11407719B2 (en) 2009-03-18 2022-08-09 Resverlogix Corp. Anti-inflammatory agents
US9238640B2 (en) 2009-03-18 2016-01-19 Resverlogix Corp. Anti-inflammatory agents
US10882828B2 (en) 2009-03-18 2021-01-05 Resverlogix Corp. Anti-inflammatory agents
US10131640B2 (en) 2009-03-18 2018-11-20 Resverlogix Corp. Anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US9610251B2 (en) 2011-11-01 2017-04-04 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US10016426B2 (en) 2011-11-01 2018-07-10 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
WO2013083024A1 (zh) * 2011-12-08 2013-06-13 上海如絮生物科技有限公司 一种苯并噻唑类化合物、其中间体、制备方法和应用
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9278940B2 (en) 2012-11-21 2016-03-08 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
US10772894B2 (en) 2015-03-13 2020-09-15 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Similar Documents

Publication Publication Date Title
DE60313624T2 (de) Derivate von heteroarylnitrilverbindungen
AP715A (en) Quinoline and quinazoline compounds useful in therapy.
DE60126611T2 (de) Ditosylatsalze von chinazolinverbindungen
EP1355903B1 (en) Pyrazole derivatives against tgf overexpression
JP3085708B2 (ja) ピペラジン誘導体
US5354759A (en) Angiotenin II antagonizing heterocyclic compounds
JP5127460B2 (ja) 化学的方法
SK135699A3 (en) Pyrazolo[3,4-d]pyrimidinedione compounds, preparation method thereof, pharmaceutical composition containing them and their use
CN111148740B (zh) 用作自噬调节剂的化合物及其制备方法和用途
AU2002357619A1 (en) Piperazine derivative
JPH10287678A (ja) ピラノアジン誘導体
TW201728590A (zh) 吡咯并［３，２－ｄ］嘧啶類化合物的製備方法及其中間體
JP4031814B2 (ja) ピペリジニルカルボニル−ピロリジンおよびメラノコルチンアゴニストとしてのそれらの使用
CA2567569A1 (en) Selective inhibitors against cdk4 and cdk6 having aminothiazole skeleton
JP4601038B2 (ja) インドリルマレイミド類
JP3152941B2 (ja) スピロ環式ドーパミンレセプターサブタイプリガンド
JP5894164B2 (ja) クロメン誘導体
JPH10287678A5 (enExample)
JP3714685B2 (ja) ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
WO2005021510A2 (en) Benzimidazole c-2 heterocycles as kinase inhibitors
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
US6011159A (en) Processes and intermediates for preparing substituted indazole derivatives
CN113278012A (zh) 用作激酶抑制剂的化合物及其应用
Alberola et al. Synthesis of [1] benzopyrano [4, 3-b] pyrrol-4 (1H)-ones from N (α)-(2-oxo-2H-1-benzopyran-4-yl) weinreb α-aminoamides
JP2002500658A (ja) ２−アミノ−７−（１−置換−２−ヒドロキシエチル）−３，５−ジヒドロピロロ［３，２−ｄ］ピリミジン−４−オン

Legal Events

Date Code Title Description
A521 Written amendment

Effective date: 20040401

Free format text: JAPANESE INTERMEDIATE CODE: A523

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070925

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070927

A02 Decision of refusal

Effective date: 20080219

Free format text: JAPANESE INTERMEDIATE CODE: A02